Mindfulness-Based Education For Women With Polycystic Ovary Syndrome
The Effect Of Mindfulness-Based Education For Women With Polycystic Ovary Syndrome On Menstrual Symptoms, Stress, And Quality of Life: A Randomized Controlled Study
Polycystic ovary syndrome (PCOS), also known as polyendocrine metabolic ovarian syndrome (PMOS), is the most common endocrinologic disorder to affect women. Despite this, the disease's pathophysiology remains unclear. This has hindered the diagnosis of the disease and the appropriate treatment for millions of individuals. The long-term health sequelae associated with PCOS, future directions, and areas of needed research in this often-overlooked disease. Women with PCOS may experience menstrual symptoms, increased stress, and difficulties in managing the physical and emotional effects of the condition. Supportive approaches that improve symptom management and quality of life may be beneficial in addition to routine care.
The aim of this randomized controlled study is to evaluate the effect of mindfulness-based PCOS education on menstrual symptoms, stress levels, and quality of life in women with PCOS. The study will examine whether a structured mindfulness-based education program can support women in managing PCOS-related symptoms and improving their overall well-being.
Women diagnosed with PCOS who meet the study eligibility criteria will be invited to participate. Participants will be randomly assigned to either the intervention group or the control group. Participants in the intervention group will receive a mindfulness-based PCOS education program, while those in the control group will receive routine care without it.
Researchers will assess participants' menstrual symptoms, stress levels, and quality of life using validated measurement tools before and after the intervention. The findings of this study will provide information about the potential role of mindfulness-based education as a supportive approach in the management of PCOS and may contribute to the development of patient-centered education programs for women with PCOS.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Polikistik Over Sendromu (PCOS), üreme çağındaki kadınları etkileyen yaygın bir endokrinolojik rahatsızlıktır.is characterized by hormonal imbalance, ovulatory dysfunction, and clinical symptoms that may negatively affect reproductive health, psychological well-being, and quality of life. The effects of PCOS extend beyond reproductive symptoms, as women with PCOS may experience increased stress, emotionyaşayabilirs, and challenges in daily functioning.
Current guidelines recommend a comprehensive approach to PCOS management that addresses not only physical symptoms but also psychological well-being and quality of life. Menstrual symptoms and stress are important factors that may influence the overall health status of women with PCOS. Therefore, supportive approaches that enance self-management skills and promote psychological well-being may play an important role in improving outcomes in PCOS.
Mindfulness-based interventions are structured approaches that aim to improve awareness of thoughts, emotions, and bodily experiences through practices of attention and acceptance. Previous studies have shown that mindfulness-based programs may support stress management and psychological ell-being in different populations. However, evidence regarding mindfulness-based education specifically designed for women with PCOS remains limited.
This randomized controlled study aims to evaluate the effect of mindfulness-based PCOS education on menstrual symptoms, stress levels, and PCOS-related quality of life in women with PCOS. The study will investigate whether integrating mindfulness practices into a structured PCOS education program provides additional benefits compared with routine care.
A total of 78 women with PCOS will participate in the study. Participants will be randomly assigned to either the mindfulness-based PCOS educatin group or the control group. The intervention group will receive a 4-week online education program that includes PCOS-related health information, lifestyle managemet, and mindfulness-based practices. The control group will continue their usual care during the study period. Participant characteristics and clinical information will be collected using a researcher-developed Introductory Information Form. Study outcomes will be assessed using the Visual Analog Scale (VAS) for menstrual pain severity, the Menstruation Symptom Scale for menstrual symptoms, the Perceived Stress Scale (PSS-10) for perceived stress levels, and the PCOS-Specific Quality of Life Questionnaire (PCOSQ-50) for disease-specific quality of life.
The study is designed to provide evidence on the effectiveness oilişkinndfulness-based education as a supportive, patient-centered approach to PCOS management. The findings may contribute to the development of comprehensive education programs that address both physical symptoms and psychosocial needs of women with PCOS.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Gonca Buran, Associate Professor
- Numéro de téléphone: +90 2242942481
- E-mail: gburan@uludag.edu.tr
Lieux d'étude
-
-
-
Bursa, Turquie (Türkiye)
- Recrutement
- Bursa Uludag University obstetrics and gynecology clinic
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
La description
Inclusion Criteria:
- Self-identify as female.
- Be of reproductive age (18-49 years).
- Have a confirmed diagnosis of Polycystic Ovary Syndrome (PCOS) based on the Rotterdam criteria.
- Be able to read, understand, and communicate in Turkish.
Have access to the internet and a device capable of participating in online education sessions.
- Be willing to attend the four-week online education program and complete all study assessments.
- Provide written informed consent before participation.
Exclusion Criteria:
- Currently pregnant or breastfeeding.
- Having a severe psychiatric disorder or cognitive impairment that may interfere with participation.
- Having a serious chronic medical condition that could affect study outcomes or prevent participation in the intervention.
- Currently participating in another interventional research study.
- Having previously received structured mindfulness training or participated in a mindfulness-based program during the study period.
- Being unable to attend the online education sessions or complete the study assessments.
- Declining or withdrawing informed consent at any stage of the study.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Mindfulness-Based Polycystic Ovary Syndrome Education
Participants in this arm will receive a four-week online mindfulness-based Polycystic Ovary Syndrome (PCOS) education program.
The program will include weekly sessions lasting approximately 90 minutes that cover PCOS-related information, symptom management, lifestyle approaches, and mindfulness-based practices.
Participants will also receive telephone-based support for questions and guidance related to the education program during the intervention period.
|
A four-week online mindfulness-based Polycystic Ovary Syndrome (PCOS) education program will be provided to participants in the experimental group.
The program will consist of weekly sessions lasting approximately 90 minutes and will include PCOS-related information, symptom management, lifestyle approaches, and mindfulness-based practices.
Participants will also receive telephone-based support for questions and guidance related to the education program throughout the intervention period.
|
|
Aucune intervention: Usual Care Control Group
Control Group
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Formulaire d'introduction
Délai: Pendant l'inscription (premier jour)
|
Les participants rempliront un formulaire d'introduction à cinq questions, y compris quatre questions sociodémographiques et une question sur les préférences de naissance.
|
Pendant l'inscription (premier jour)
|
|
PCOS-Specific Quality of Life
Délai: During registration (first day)
|
PCOS-specific quality of life will be assessed using the Polycystic Ovary Syndrome Quality of Life Questionnaire (PCOSQ-50) before the education program.
Baseline quality-of-life scores will be used to describe participants' initial status and to compare baseline characteristics between the intervention and control groups.
|
During registration (first day)
|
|
Menstrual Symptoms
Délai: Day 1 (During recruitment)
|
Women's current menstrual symptoms will be assessed using the Menstrual Symptom Scale during enrollment prior to the awareness-based Polycystic Ovary Syndrome (PCOS) education.
Baseline symptom scores will be compared between the intervention and control groups throughout the study time points.
|
Day 1 (During recruitment)
|
|
Perceived Stress
Délai: Day 1 (During recruitment)
|
Baseline perceived stress levels of participants will be assessed using the Perceived Stress Scale (PSS-10) before the education program.
Baseline stress levels will be evaluated to describe participants' initial status and compare baseline characteristics between the intervention and control groups.
|
Day 1 (During recruitment)
|
|
Menstrual Pain Severity
Délai: Day 1 (during recruitment)
|
Women's current menstrual pain severity will be evaluated using the Visual Analog Scale (VAS) before intervention.
Participants will rate their menstrual pain intensity on a 10-cm scale ranging from 0 (no pain) to 10 (worst possible pain).
|
Day 1 (during recruitment)
|
|
After intervention Menstrual Symptoms
Délai: immediately after the 4-week education program
|
The effect of mindfulness-based Polycystic Ovary Syndrome (PCOS) education on menstrual symptoms will be evaluated using the Menstruation Symptom Scale.
Changes in menstrual symptom scores from baseline will be compared between the intervention and control groups across the study time points.
|
immediately after the 4-week education program
|
|
Immediately after intervention, PCOS-Specific Quality of Life (PCOSQ-50)
Délai: Immediately after the 4-week education program
|
The effect of mindfulness-based Polycystic Ovary Syndrome (PCOS) education on PCOS-specific quality of life will be evaluated using the Polycystic Ovary Syndrome Quality of Life Questionnaire (PCOSQ-50).
Changes in quality-of-life scores from baseline will be compared between the intervention and control groups.
|
Immediately after the 4-week education program
|
|
After intervention Perceived Stress
Délai: immediately after the 4-week education program
|
The effect of mindfulness-based education on Polycystic Ovary Syndrome (PCOS) on perceived stress levels will be evaluated using the Perceived Stress Scale (PSS-10).
Changes in perceived stress scores from baseline will be compared between the intervention and control groups at each study time point.
|
immediately after the 4-week education program
|
|
After intervention Menstrual Pain Severity
Délai: immediately after the 4-week education program
|
The effect of mindfulness-based Polycystic Ovary Syndrome (PCOS) education on menstrual pain severity will be evaluated using the Visual Analog Scale (VAS).
Participants will rate their menstrual pain intensity on a 10-cm scale ranging from 0 (no pain) to 10 (worst possible pain).
Changes in menstrual pain severity scores from baseline will be compared between the intervention and control groups at each study time point.
|
immediately after the 4-week education program
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in PCOS-Specific Quality of Life
Délai: at the 8-week follow-up.
|
Chances PCOS-specific quality of life will be assessed using the Polycystic Ovary Syndrome Quality of Life Questionnaire (PCOSQ-50).
Changes in quality-of-life scores will be compared between the intervention and control groups at the 8-week follow-up.
|
at the 8-week follow-up.
|
|
Change in Perceived Stress
Délai: 8-week follow-up
|
The effect of mindfulness-based education on Polycystic Ovary Syndrome (PCOS) on perceived stress levels will be evaluated using the Perceived Stress Scale (PSS-10).
Changes in perceived stress scores will be compared between the intervention and control groups at each study time point.
|
8-week follow-up
|
|
Change in Menstrual Symptoms
Délai: 8-week follow-up
|
The effect of mindfulness-based Polycystic Ovary Syndrome (PCOS) education on menstrual symptoms will be evaluated using the Menstruation Symptom Scale.
Changes in menstrual symptom scores will be compared between the intervention and control groups at each study time point.
|
8-week follow-up
|
|
Change in Menstrual Pain Severity
Délai: 8-week follow-up
|
The effect of mindfulness-based Polycystic Ovary Syndrome (PCOS) education on menstrual pain severity will be evaluated using the Visual Analog Scale (VAS).
Participants will rate their menstrual pain intensity on a 10-cm scale ranging from 0 (no pain) to 10 (worst possible pain).
Changes in pain severity scores will be compared between the intervention and control groups.
|
8-week follow-up
|
Collaborateurs et enquêteurs
Parrainer
Publications et liens utiles
Publications générales
- Chesney MA, Tasto DL. The development of the menstrual symptom questionnaire. Behav Res Ther. 1975 Oct;13(4):237-44. doi: 10.1016/0005-7967(75)90028-5. No abstract available.
- Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, Costello MF, Boivin J, Redman LM, Boyle JA, Norman RJ, Mousa A, Joham AE. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023 Sep 18;108(10):2447-2469. doi: 10.1210/clinem/dgad463.
- Galante J, Friedrich C; Collaboration of Mindfulness Trials (CoMinT) 3; Dalgleish T, Jones PB, White IR; Collaboration of Mindfulness Trials (CoMinT). Individual participant data systematic review and meta-analysis of randomised controlled trials assessing adult mindfulness-based programmes for mental health promotion in non-clinical settings. Nat Ment Health. 2023 Jul 10;1(7):462-476. doi: 10.1038/s44220-023-00081-5.
- Nasiri-Amiri F, Ramezani Tehrani F, Simbar M, Montazeri A, Mohammadpour RA. Health-related quality of life questionnaire for polycystic ovary syndrome (PCOSQ-50): development and psychometric properties. Qual Life Res. 2016 Jul;25(7):1791-801. doi: 10.1007/s11136-016-1232-7. Epub 2016 Jan 27.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
- Maladies urogénitales
- Maladies génitales
- La douleur
- Manifestations neurologiques
- Maladies du système endocrinien
- Processus pathologiques
- Tumeurs
- Maladies urogénitales féminines
- Maladies urogénitales féminines et complications de la grossesse
- Maladies génitales, femme
- Maladies ovariennes
- Maladies annexielles
- Troubles gonadiques
- Kystes de l'ovaire
- Kystes
- Douleur pelvienne
- Troubles menstruels
- Conditions pathologiques, signes et symptômes
- Signes et symptômes
- Syndrome des ovaires polykystiques
- Dysménorrhée
- Facteurs socioéconomiques
- Caractéristiques de la population
- Statut éducatif
Autres numéros d'identification d'étude
- 2026/148/5
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .